High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of intergroup trial E1694/S9512/C509801

J. M. Kirkwood*, J. G. Ibrahim, J. A. Sosman, V. K. Sondak, S. S. Agarwala, M. S. Ernstoff, U. Rao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

759 Scopus citations

Fingerprint Dive into the research topics of 'High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of intergroup trial E1694/S9512/C509801'. Together they form a unique fingerprint.

Medicine & Life Sciences